Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03380000 · ClinicalTrials.gov registry record · Phase 2
Effect of Beetroot Juice on Blood Pressure Regulation in Post Menopausal Women
A Phase 2 study, sponsored by Penn State University.
- Completed
- Registry status
- Phase 2
- Development phase
- 16
- Enrollment target
NCT03380000: Completed Phase 2 study, sponsored by Penn State University.
NCT03380000 is a Phase 2 study that has completed, run by Penn State University. The registered enrollment target is 16 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (88% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03380000, a Phase 2 study, has completed, sponsored by Penn State University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 16 participants
- Enrollment target
Study Summary
In this study the investigators will test the hypothesis that acute consumption of inorganic nitrate (supplied in concentrated beetroot juice) reduces artery stiffness and resting blood pressure, and lessens the rise in blood pressure during handgrip exercise in postmenopausal women. Understanding and improving artery function and blood pressure regulation in women is important because they undergo accelerated arterial stiffening after menopause and have much larger increases in blood pressure when they exercise compared with either premenopausal women or men of similar age.
Primary Outcome
Aortic Blood pressures were measured in the arm (cuff) and estimated in the aorta (radial artery tonometry).
Interventions
- DRUG Beetroot juice
- DRUG Beetroot juice placebo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2014-09-12 |
| Est. Completion | 2020-01 |
| Phase | Phase 2 |
What the finished NCT03380000 record still lists
NCT03380000 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 16 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (88% lower).
The record links to 0 conditions, and to 2 interventions - of which Beetroot juice is the first listed.
NCT03380000 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03380000 about?
NCT03380000 is a clinical study titled "Effect of Beetroot Juice on Blood Pressure Regulation in Post Menopausal Women". In this study the investigators will test the hypothesis that acute consumption of inorganic nitrate (supplied in concentrated beetroot juice) reduces artery stiffness and resting blood pressure, and lessens the rise in blood pressure during handgrip exercise in postmenopausal women. Understanding a...
What is the current status of trial NCT03380000?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 16 participants. The study started on 2014-09-12. Estimated completion is 2020-01.
What interventions are being tested in trial NCT03380000?
The interventions under investigation include: Beetroot juice (DRUG), Beetroot juice placebo (DRUG).
Who is sponsoring clinical trial NCT03380000?
This trial is sponsored by Penn State University, which has 219 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03380000's enrollment target sits among peer trials
16 1908th of 2000 higher than 82 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02422641 · 16 participants · Phase 2
Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis
- NCT02851758 · 16 participants · NA
Transplantation of Autologously Derived Mitochondria Following Ischemia
- NCT03291028 · 16 participants
Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma
- NCT03425526 · 16 participants · Phase 1
Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI